- Filed
- Mar 9, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Mar 9, 2026 | 33.53M sh |
| Shares Diluted | Q1 2026 · Jan 31, 2026 | 33.24M sh |
| Shares Diluted | Q1 2026 · Jan 31, 2025 | 32.2M sh |
| Operating Cash Flow | Q1 2026 · Jan 31, 2026 | −$2.61M |
| Operating Cash Flow | Q1 2026 · Jan 31, 2025 | −$2.9M |
| Short Term Investments | Q1 2026 · Jan 31, 2026 | $12.66M |
| Short Term Investments | Q1 2026 · Oct 31, 2025 | $13.93M |
| Cash And Equivalents | Q1 2026 · Jan 31, 2026 | $1.55M |
| Cash And Equivalents | Q1 2026 · Oct 31, 2025 | $1.24M |
| Stockholders Equity | Q1 2026 · Jan 31, 2026 | $15.08M |
| Stockholders Equity | Q1 2026 · Oct 31, 2025 | $15.16M |
| Current Liabilities | Q1 2026 · Jan 31, 2026 | $1.24M |
| Current Liabilities | Q1 2026 · Oct 31, 2025 | $1.97M |
| Total Liabilities | Q1 2026 · Jan 31, 2026 | $1.39M |
| Total Liabilities | Q1 2026 · Oct 31, 2025 | $2.13M |
| Current Assets | Q1 2026 · Jan 31, 2026 | $15.05M |
| Current Assets | Q1 2026 · Oct 31, 2025 | $15.89M |
| Total Assets | Q1 2026 · Jan 31, 2026 | $15.23M |
| Total Assets | Q1 2026 · Oct 31, 2025 | $16.08M |
| Eps Diluted | Q1 2026 · Jan 31, 2026 | −$0.08 |
| Eps Diluted | Q1 2026 · Jan 31, 2025 | −$0.10 |
| Eps Basic | Q1 2026 · Jan 31, 2026 | −$0.08 |
| Eps Basic | Q1 2026 · Jan 31, 2025 | −$0.10 |
| Rd Expense | Q1 2026 · Jan 31, 2026 | $1.1M |
| Rd Expense | Q1 2026 · Jan 31, 2025 | $1.55M |
| Net Income | Q1 2026 · Jan 31, 2026 | −$2.57M |
| Net Income | Q1 2026 · Jan 31, 2025 | −$3.18M |
| Operating Income | Q1 2026 · Jan 31, 2026 | −$2.72M |
| Operating Income | Q1 2026 · Jan 31, 2025 | −$3.39M |